Android app on Google Play

Aegis Starts SGYP, IRWD, AMRN, MDVN at Buy, PLX at Hold

June 12, 2012 8:54 AM EDT Send to a Friend
Get Alerts SGYP Hot Sheet
Price: $4.34 -1.36%

Rating Summary:
    9 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 9 | New: 22
Trade SGYP Now!
Join SI Premium – FREE
Aegis Capital's Raghuram Selvaraju initiated coverage on a number of Biotech stocks Tuesday morning:
  • Synergy Pharma (Nasdaq: SGYP) with a Buy rating and a $25 price target.
  • Ironwood Pharma (Nasdaq: IRWD) with a Buy rating and a $17 price target.
  • Amarin (Nasdaq: AMRN) with a Buy rating and a $25 price target.
  • Medivation (Nasdaq: MDVN) with a Buy rating and a $120 price target.
  • Protalix (NYSE: PLX) with a Hold rating
Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.




You May Also Be Interested In


Related Categories

New Coverage

Add Your Comment